Baidu
map

Nat. Immunol:转录因子Lyl-1在产生早期T细胞系祖细胞中发挥关键性作用

2012-07-18 ZinFingerNase 生物谷

T细胞是在胸腺中产生的一类非常重要的细胞,能够协调机体对癌症或感染产生的免疫反应。在一项最新研究中,来自美国贝勒医学院的研究人员领导的一个研究小组发现转录因子Lyl-1是产生能够变成T细胞的最早的细胞所必需的。相关研究结果于2012年7月8日在线发表在Nature Immunology期刊上。 论文通讯作者、贝勒医学院干细胞与再生医学中心主任Margaret Goodell说,这些最早的祖细胞(

T细胞是在胸腺中产生的一类非常重要的细胞,能够协调机体对癌症或感染产生的免疫反应。在一项最新研究中,来自美国贝勒医学院的研究人员领导的一个研究小组发现转录因子Lyl-1是产生能够变成T细胞的最早的细胞所必需的。相关研究结果于2012年7月8日在线发表在Nature Immunology期刊上。

论文通讯作者、贝勒医学院干细胞与再生医学中心主任Margaret Goodell说,这些最早的祖细胞(也被称作早期T细胞系祖细胞)是被鉴定为最终变成T细胞的最为原始的细胞。如果没有Lyl-1,这些早期T细胞系祖细胞(early T lineage progenitor cell)中只有少量得以产生。

Goodell实验室博士后学生Fabian Zohren博士发现缺乏表达这种转录因子的基因的小鼠患上T细胞缺乏症,尤其是这些早期祖细胞数量特别少。

Goodell说,“这表明这些早期T细胞系祖细胞的产生确实依赖Lyl-1。我们认为Lyl-1控制着一种允许这些至为重要的祖细胞存活和增殖的程序。”

这一发现可能也有助于人们理解一种类型的白血病,即急性T淋巴细胞白血病(T-cell acute lymphoblastic leukemia)。研究人员发现,就这种类型的疾病而言,癌细胞类似于这些早期T细胞系祖细胞的白血病预后最差。此外,这些癌细胞也有高水平的Lyl-1。

一种可能的解释就是患有这种类型的T淋巴细胞白血病的病人体内的T细胞系祖细胞继续表达Lyl-1,因而继续增殖。在早期T细胞系祖细胞中过量的Lyl-1能够阻止早期T细胞系祖细胞分化为有活性的T细胞。Goodell说,在未来,他想测试这种假设。

本文编译自Transcription factor Lyl-1 critical in producing early T-cell progenitors

doi: 10.1038/ni.2365
PMC:
PMID:

The transcription factor Lyl-1 regulates lymphoid specification and the maintenance of early T lineage progenitors

Fabian Zohren, George P Souroullas, Min Luo, Ulrike Gerdemann, Maria R Imperato, Nicola K Wilson, Berthold Göttgens, Georgi L Lukov & Margaret A Goodell

Thymopoiesis depends on the recruitment and expansion of bone marrow–derived progenitor populations; tight regulation of these processes is required for maintenance of the homeostasis of the T lineage. Lyl-1, a transcription factor that regulates hematopoietic progenitors, is expressed in thymocyte progenitors until T cell commitment. Here we demonstrate a requirement for Lyl-1 in lymphoid specification and the maintenance of early T lineage progenitors (ETPs). Lyl-1 deficiency resulted in profound defects in the generation of lymphoid-primed multipotent progenitors (LMPPs), common lymphoid progenitors (CLPs) and ETPs. Lyl-1-deficient ETPs and thymocyte progenitors at the CD4−CD8− double-negative 2 (DN2) stage showed more apoptosis, blocked differentiation and impaired population expansion. We identified Gfi1 as a critical transcriptional target of Lyl-1-mediated lymphopoiesis of T cells. Thus, Lyl-1 is a pivotal component of a transcriptional program that controls the lymphoid specification and maintenance of ETPs.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1747165, encodeId=48861e47165ae, content=<a href='/topic/show?id=832e93345c3' target=_blank style='color:#2F92EE;'>#转录#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93345, encryptionId=832e93345c3, topicName=转录)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58df35929710, createdName=mjldent, createdTime=Sun Aug 05 10:08:00 CST 2012, time=2012-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879314, encodeId=e8d818e93141b, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Feb 11 04:08:00 CST 2013, time=2013-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512406, encodeId=daf41512406bc, content=<a href='/topic/show?id=f802e4102cb' target=_blank style='color:#2F92EE;'>#祖细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74102, encryptionId=f802e4102cb, topicName=祖细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f18310470858, createdName=12498636m52(暂无昵称), createdTime=Fri Jul 20 02:08:00 CST 2012, time=2012-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1537443, encodeId=ba10153e443cb, content=<a href='/topic/show?id=798a93348bb' target=_blank style='color:#2F92EE;'>#转录因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93348, encryptionId=798a93348bb, topicName=转录因子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8c712868269, createdName=lanyan20020090, createdTime=Fri Jul 20 02:08:00 CST 2012, time=2012-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553986, encodeId=90d0155398625, content=<a href='/topic/show?id=7482e7994d0' target=_blank style='color:#2F92EE;'>#细胞系#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77994, encryptionId=7482e7994d0, topicName=细胞系)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c9f14484011, createdName=zhangxingru, createdTime=Fri Jul 20 02:08:00 CST 2012, time=2012-07-20, status=1, ipAttribution=)]
    2012-08-05 mjldent
  2. [GetPortalCommentsPageByObjectIdResponse(id=1747165, encodeId=48861e47165ae, content=<a href='/topic/show?id=832e93345c3' target=_blank style='color:#2F92EE;'>#转录#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93345, encryptionId=832e93345c3, topicName=转录)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58df35929710, createdName=mjldent, createdTime=Sun Aug 05 10:08:00 CST 2012, time=2012-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879314, encodeId=e8d818e93141b, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Feb 11 04:08:00 CST 2013, time=2013-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512406, encodeId=daf41512406bc, content=<a href='/topic/show?id=f802e4102cb' target=_blank style='color:#2F92EE;'>#祖细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74102, encryptionId=f802e4102cb, topicName=祖细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f18310470858, createdName=12498636m52(暂无昵称), createdTime=Fri Jul 20 02:08:00 CST 2012, time=2012-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1537443, encodeId=ba10153e443cb, content=<a href='/topic/show?id=798a93348bb' target=_blank style='color:#2F92EE;'>#转录因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93348, encryptionId=798a93348bb, topicName=转录因子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8c712868269, createdName=lanyan20020090, createdTime=Fri Jul 20 02:08:00 CST 2012, time=2012-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553986, encodeId=90d0155398625, content=<a href='/topic/show?id=7482e7994d0' target=_blank style='color:#2F92EE;'>#细胞系#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77994, encryptionId=7482e7994d0, topicName=细胞系)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c9f14484011, createdName=zhangxingru, createdTime=Fri Jul 20 02:08:00 CST 2012, time=2012-07-20, status=1, ipAttribution=)]
    2013-02-11 liye789132251
  3. [GetPortalCommentsPageByObjectIdResponse(id=1747165, encodeId=48861e47165ae, content=<a href='/topic/show?id=832e93345c3' target=_blank style='color:#2F92EE;'>#转录#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93345, encryptionId=832e93345c3, topicName=转录)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58df35929710, createdName=mjldent, createdTime=Sun Aug 05 10:08:00 CST 2012, time=2012-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879314, encodeId=e8d818e93141b, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Feb 11 04:08:00 CST 2013, time=2013-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512406, encodeId=daf41512406bc, content=<a href='/topic/show?id=f802e4102cb' target=_blank style='color:#2F92EE;'>#祖细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74102, encryptionId=f802e4102cb, topicName=祖细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f18310470858, createdName=12498636m52(暂无昵称), createdTime=Fri Jul 20 02:08:00 CST 2012, time=2012-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1537443, encodeId=ba10153e443cb, content=<a href='/topic/show?id=798a93348bb' target=_blank style='color:#2F92EE;'>#转录因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93348, encryptionId=798a93348bb, topicName=转录因子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8c712868269, createdName=lanyan20020090, createdTime=Fri Jul 20 02:08:00 CST 2012, time=2012-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553986, encodeId=90d0155398625, content=<a href='/topic/show?id=7482e7994d0' target=_blank style='color:#2F92EE;'>#细胞系#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77994, encryptionId=7482e7994d0, topicName=细胞系)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c9f14484011, createdName=zhangxingru, createdTime=Fri Jul 20 02:08:00 CST 2012, time=2012-07-20, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1747165, encodeId=48861e47165ae, content=<a href='/topic/show?id=832e93345c3' target=_blank style='color:#2F92EE;'>#转录#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93345, encryptionId=832e93345c3, topicName=转录)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58df35929710, createdName=mjldent, createdTime=Sun Aug 05 10:08:00 CST 2012, time=2012-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879314, encodeId=e8d818e93141b, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Feb 11 04:08:00 CST 2013, time=2013-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512406, encodeId=daf41512406bc, content=<a href='/topic/show?id=f802e4102cb' target=_blank style='color:#2F92EE;'>#祖细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74102, encryptionId=f802e4102cb, topicName=祖细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f18310470858, createdName=12498636m52(暂无昵称), createdTime=Fri Jul 20 02:08:00 CST 2012, time=2012-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1537443, encodeId=ba10153e443cb, content=<a href='/topic/show?id=798a93348bb' target=_blank style='color:#2F92EE;'>#转录因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93348, encryptionId=798a93348bb, topicName=转录因子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8c712868269, createdName=lanyan20020090, createdTime=Fri Jul 20 02:08:00 CST 2012, time=2012-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553986, encodeId=90d0155398625, content=<a href='/topic/show?id=7482e7994d0' target=_blank style='color:#2F92EE;'>#细胞系#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77994, encryptionId=7482e7994d0, topicName=细胞系)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c9f14484011, createdName=zhangxingru, createdTime=Fri Jul 20 02:08:00 CST 2012, time=2012-07-20, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1747165, encodeId=48861e47165ae, content=<a href='/topic/show?id=832e93345c3' target=_blank style='color:#2F92EE;'>#转录#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93345, encryptionId=832e93345c3, topicName=转录)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58df35929710, createdName=mjldent, createdTime=Sun Aug 05 10:08:00 CST 2012, time=2012-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879314, encodeId=e8d818e93141b, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Feb 11 04:08:00 CST 2013, time=2013-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512406, encodeId=daf41512406bc, content=<a href='/topic/show?id=f802e4102cb' target=_blank style='color:#2F92EE;'>#祖细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74102, encryptionId=f802e4102cb, topicName=祖细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f18310470858, createdName=12498636m52(暂无昵称), createdTime=Fri Jul 20 02:08:00 CST 2012, time=2012-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1537443, encodeId=ba10153e443cb, content=<a href='/topic/show?id=798a93348bb' target=_blank style='color:#2F92EE;'>#转录因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93348, encryptionId=798a93348bb, topicName=转录因子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8c712868269, createdName=lanyan20020090, createdTime=Fri Jul 20 02:08:00 CST 2012, time=2012-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553986, encodeId=90d0155398625, content=<a href='/topic/show?id=7482e7994d0' target=_blank style='color:#2F92EE;'>#细胞系#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77994, encryptionId=7482e7994d0, topicName=细胞系)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c9f14484011, createdName=zhangxingru, createdTime=Fri Jul 20 02:08:00 CST 2012, time=2012-07-20, status=1, ipAttribution=)]

相关资讯

PLoS ONE:转录因子c-Jun保护肝免受β-连环蛋白损伤

Wnt/β-catenin信号通路在肝功能的正常至关重要,而在肝细胞癌(HCC)中,这条信号通路进场是失调的。因此,分析β-catenin活化的早期表型和分子事件对更好地了解肝癌发病是非常有必要的。 AP-1转录因子c-Jun是一个假定的β-catenin靶基因,它能促进肝细胞的存、增殖以及肝癌的发生,这表明c-Jun可能是β-catenin在肝脏中的主要作用靶蛋白。为了解决这个问题,近日研究人

Baidu
map
Baidu
map
Baidu
map